DEC 2014 ARTICLE LIST >>
PharmaTutor (December- 2014)
ISSN: 2347 - 7881
(Volume 2, Issue 12)
Received On: 16/10/2014; Accepted On: 24/10/2014; Published On: 01/12/2014
AUTHORS: Balay Ragini*, A.Pavani, R.Raja Reddy
Malla Reddy Pharmacy College,
Maisammaguda(via-hakimpet), Secunderabad, Telengana. india
ragini.balay@gmail.com
ABSTRACT: Cefuroxime Axetil is a second generation antibacterial belongs to Cephalosporin Group. The drug undergoes rapid metabolism in intestinal mucosa due to change in pH Environment and hence has decreased oral bioavailability. The aim of present investigation is to increase the gastric residence time by preparing gastroretentive tablets here by improving bioavailability of Cefuroxime Axetil. A simple UV spectrophotometric method has been employed for the estimation of Cefuroxime Axetil at 281 nm. A floating drug delivery system (FDDS) was developed using gas-forming agents, like sodium bicarbonate, sodium alginate and hydrocolloids like hydroxyl propyl methyl cellulose (HPMC) and guggul. The prepared tablets were evaluated in terms of their precompression parameters, physical characteristics, In vitro release, buoyancy lag-time and swelling index. The formulations were optimized for the different grades of HPMC, and its concentrations and combinations. The results of the In vitro release studies showed that the optimized formulation F3 could sustain drug release of 92% and remain buoyant for 10h. The optimized formulation was subjected to various kinetic release investigations and it was found that the mechanism of drug release was predominately Higuhci with non fickian diffusion. Finally the tablets formulations found to be economical and may overcome the draw backs associated with the drug during its absorption.
How to cite this article: R Balay, A Pavani, RR Reddy; Formulation and Evaluation of Gastroretentive Drug Delivery System of Cefuroxime Axetil; PharmaTutor; 2014; 2(12); 114-122
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Alagusundaram M, Maadhusudan Chetty. Int J Chem Tech Res, 2009; 1(3): 526-34.
2. Vyas, RK Khar. Targeted and controlled drug delivery, 2007; Edition.418.
3. Whitehead L, J T Fell, J H Collett. Eur J Pharma Sci, 1996; 4 (1): 182.
4. Mojaverian P, Vlasses P H, Kellner P M. Pharm Res, 1988; 10: 639–44.
5. Perry, C.M., Brogden, R.N., 1996. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 52, 125–158.
6. Crisp, H.A., Clayton, J.C., 1985. Amorphous form of cefuroxime ester. US Patent 4, 562, 181.
7. Ravindra Dhumal, Samitkumar T Rajmane, Sanjay T Dhumal, Atmaram P Pawar: Design and evaluation of bilayer floating tablets of cefuroxime axetil for bimodal release. Journal of Scientific & Indusrtial Research 2006; Vol. 65 Issue 10: 812-816.
8. Kavita.K, Sudhir K. Yadav ,Tamizhamani T: Formulation and Evaluation of Floating Tablets of RHCL Using Natural and Synthetic Polymers. International Journal of Pharm Tech Research CODEN (USA) 2010; Vol.2, No.2: 1513-1519.
9. Pare A, Yadav SK and Patil UK: Formulation and Evaluation of Effervescent Floating Tablet of Amlodipine Besylate. Research J. Pharm. and Tech. 2008; Vol 1 Issue 4: 526-530.
10. Shantveer V. Salger, Lingaraj S. Danki, Shivanand Hiremath, Abdul Sayeed : Preparation and evaluation of sustained release matrix tablets of propranolol hydrochloride. International journal of pharma and bio sciences 2010; Vol 1 Issue 4: 227-241.
11. Shelke S, Dongre Santosh, Amit Rathi, etals. Development and validation of UV Spectroscopic method of Cefuroxime axetil in bulk and Pharmaceutical Formulation: Asian J.Research Chem. April 2009.p.222-224.
12. Md. Mofizur Rahman1, Sayeed Hasan, Md. Ashiqul Alam, Sumon Roy,et.al. : Formulation and evaluation of Ranolazine sustained release matrix tablets using Eudragit and HPMC. International Journal of pharmaceutical and biomedical research 2011; Vol 2 Issue 1: 7-12.